Peptide/Protein Performance Clinical form Reference
rCatL
SPE: 95.71 % SENS: 95.56 %
Visceral Leishmaniasis
DOI: 10.1371/journal.pntd.0003426
rLiHyS
SPE: 100 % SENS: 100 %
Visceral Leishmaniasis and Cutaneous Leishmaniasis
DOI: 10.1016/j.parint.20 8.02.001
rPHB + peptídeo sintético (para LT)
SPE: 98,31 % SENS: 84,91 %
Visceral Leishmaniasis and Cutaneous Leishmaniasis
DOI: 10.1016/j.jim.2019.112641
rLbMAPK3 rLbMAPK4 rLbMAPK3 SPE: 71.43% SENS: 83.08% rLbMAPK4: SPE:97.14 % SENS: 75.38 %
Visceral Leishmaniasis and Cutaneous Leishmaniasis
DOI: 10.1007/s00253-014-6168-7
rLbHyM
SPE: 98.0% SENS:100 %
Leishmaniose Tegumentar
DOI: 10.1007/s00436-017-5397-y
LbK39
SPE: 98% SENS: 88%
Visceral Leishmaniasis and Cutaneous Leishmaniasis
DOI: 10.1016/j.onehlt.2019.100111
rLiHypA
SPE: 100 % SENS: 98,2 %
Visceral Leishmaniasis and Cutaneous Leishmaniasis
DOI: 10.1016/j.cellimm.2017.06.001
rLB8E e rLb6H
rLb6H SPE: 100.0% % SENS: 93,9 % rLb8E SPE: 83.3% SENS: 83.3%
Cutaneous Leishmaniasis
DOI: 10.1128/jcm.01904-16
rHSP70 e rH2A
SPE: 100 % SENS: 98 %
Cutaneous Leishmaniasis
DOI: 10.1371/journal.pone.0066110
rLiHyC + PeptC
SPE: 100 % SENS: 100 %
Visceral Leishmaniasis
DOI: 10.1016/j.actatropica.2019.105318
ChimLeish
SPE: 100 % SENS: 100 %
Visceral Leishmaniasis
DOI: 10.1007/s00436-021-07342-1
rSMP-3
SPE: > 90 % SENS: > 90 %
Visceral Leishmaniasis and Cutaneous Leishmaniasis
DOI: 10.1016/j.imbio.2018.09.003.
rEF1b
SPE: 100 % SENS: 100 %
Visceral Leishmaniasis and Cutaneous Leishmaniasis
DOI: 10.1016/j.micpath.2019.103783
Synthetic peptides (P1, P2, P3) e MIX(P1P2P3)
MIX SENS: 79%% P1 SENS: 72% SPE: 78-100%
Visceral Leishmaniasis
DOI: 10.1155/2017/5871043
rKDDR
SPE: 100% SENS: 92,86%
Visceral Leishmaniasis
DOI: 10.1371/journal.pone.0211719
rK28
ESP: 98.6 % SENS: > 96 %
Visceral Leishmaniasis
DOI: 10.1186/s13071-016-1667-2
rLiHyV
SPE: 95.4% SENS: 85%
Cutaneous Leishmaniasis
DOI: 10.1186/s13071-015-0964-5